Metabolic Disease Epidemics: Emerging Challenges in Regenerative Medicine

Raquel Costa-Almeida¹, Rui L Reis², Manuela E Gomes³

Affiliations

¹ 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
² 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal.
³ 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal. Electronic address: megomes@i3bs.uminho.pt.

PMID: 30704823
DOI: 10.1016/j.tem.2019.01.001

Review

Metabolic Disease Epidemics: Emerging Challenges in Regenerative Medicine

Raquel Costa-Almeida et al. Trends Endocrinol Metab. 2019 Mar.

. 2019 Mar;30(3):147-149.

doi: 10.1016/j.tem.2019.01.001. Epub 2019 Jan 29.

Authors

Raquel Costa-Almeida¹, Rui L Reis², Manuela E Gomes³

Affiliations

¹ 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
² 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal.
³ 3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal. Electronic address: megomes@i3bs.uminho.pt.

PMID: 30704823
DOI: 10.1016/j.tem.2019.01.001

Abstract

The interplay between cell/tissue damage caused by metabolic dysfunction and regenerative potential remains elusive. The tissue engineering and regenerative medicine (TERM) field is now facing a worldwide epidemic of obesity. This Forum article uncovers prospective questions to be addressed in TERM toward the development of effective regenerative therapies adjusted to these new demands.

Keywords: adipose stem cells; diabetes; metabolic syndrome; obesity; tissue engineering.

PubMed Disclaimer

Cited by

Mesenchymal Stem Cells Empowering Tendon Regenerative Therapies.
Costa-Almeida R, Calejo I, Gomes ME. Costa-Almeida R, et al. Int J Mol Sci. 2019 Jun 19;20(12):3002. doi: 10.3390/ijms20123002. Int J Mol Sci. 2019. PMID: 31248196 Free PMC article. Review.
Assessing the role of combination of stem cell and light-based treatments on skin wound repair: A meta-analysis.
Zheng M, Zhang H, Wu H, Xie J, Chen Q, Jiang Y, Zhao D. Zheng M, et al. Int Wound J. 2023 Dec;20(10):4272-4280. doi: 10.1111/iwj.14329. Epub 2023 Jul 31. Int Wound J. 2023. Retraction in: Int Wound J. 2025 Feb;22(2):e70226. doi: 10.1111/iwj.70226. PMID: 37525509 Free PMC article. Retracted.
Designer Stem Cells: Genome Engineering and the Next Generation of Cell-Based Therapies.
Guilak F, Pferdehirt L, Ross AK, Choi YR, Collins K, Nims RJ, Katz DB, Klimak M, Tabbaa S, Pham CTN. Guilak F, et al. J Orthop Res. 2019 Jun;37(6):1287-1293. doi: 10.1002/jor.24304. Epub 2019 May 2. J Orthop Res. 2019. PMID: 30977548 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Metabolic Disease Epidemics: Emerging Challenges in Regenerative Medicine

Affiliations

Metabolic Disease Epidemics: Emerging Challenges in Regenerative Medicine

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical